Zevra Therapeutics
ZVRA
#6812
Rank
C$1.03 B
Marketcap
C$17.55
Share price
3.49%
Change (1 day)
10.00%
Change (1 year)

Revenue for Zevra Therapeutics (ZVRA)

Revenue in 2026 (TTM): C$0.16 Billion

According to Zevra Therapeutics's latest financial reports the company's current revenue (TTM ) is C$0.17 Billion. In 2025 the company made a revenue of C$0.14 Billion an increase over the revenue in the year 2024 that were of C$33.88 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zevra Therapeutics from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) C$0.16 B15.63%
2025 C$0.14 B330.33%
2024 C$33.88 M-7.97%
2023 C$36.81 M159.44%
2022 C$14.19 M-61.13%
2021 C$36.51 M115.5%
2020 C$16.94 M1.04%
2019 C$16.76 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A